Policy Positions and Submissions to Government
| Date | Title | Action |
| January 2020 | Roche Pharmaceuticals Pre-Budget Submission 2020-21 | Download |
| April 2019 | Roche Election Policy Agenda 2019 | Download |
| November 2017 | Access to Medicines for Rare Diseases | Download |
| February 2017 | Access to Medicines Under the PBS | Download |
| October 2016 | Access to Medicines Outside of Public Funding | Download |
| December 2016 | Biosimilars | Download |
| October 2017 | Cancer Medicines | Download |
| October 2016 | Clinical Data Transparency | Download |
| September 2018 | Clinical Trials in Australia | Download |
| October 2016 | Engaging with Healthcare Professionals (HCPs) and health-related organisations |
Download |
| October 2016 | Engaging with Health Consumer Organisations | Download |
| October 2016 | Ethical and Sustainable Business | Download |
| February 2017 | Health Technology Assessment | Download |
| September 2018 | Intellectual Property in Medicines | Download |
| September 2016 | Personalised Healthcare | Download |
| February 2017 | Pricing | Download |
| October 2017 | Regulatory Assessment of Prescription Medicines | Download |
| December 2017 | Roche Pre-Budget Submission 2017-18 | Download |
| February 2017 | Value of Medicines Innovation | Download |